FVIII

DRUG4 trials

Sponsors

Hospices Civils de Lyon, Chulalongkorn University, Children's Hospital Los Angeles, Wayne State University

Conditions

Hemophilia AImmune Tolerance

Phase 4

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

CompletedNCT02727647

Chulalongkorn UniversityHemophilia A

Start: 2015-05-31End: 2016-03-31Updated: 2016-04-04

Preventing Inhibitor Recurrence Indefinitely

Children's Hospital Los AngelesHemophilia A, Immune Tolerance

Start: 2020-09-21End: 2025-04-20Target: 52Updated: 2023-10-05

Unknown Phase

Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

TerminatedNCT00995046

Hospices Civils de LyonHemophilia A

Start: 2009-09-30Updated: 2013-05-14

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

RecruitingNCT05022459

Wayne State UniversityHemophilia A

Start: 2023-08-16End: 2029-03-01Target: 72Updated: 2026-07-02